Alurar rigakafi sune a yanki mai rikitarwa, wanda saboda tsarin rigakafi yana da rikitarwa sosai. Allurar rigakafin da aka yi niyya suna da tasiri, kuma ba zai yiwu a hango ko menene suke ba.
Kungiyar Farfesa Peter Aaby ta yi kasa bincike akan illolin alluran rigakafi a cikin gwaje-gwajen da ba a sani ba da kuma a cikin binciken filin. Tawagarsa ta gano cewa duk masu raye-rayen da aka rage, suna rage yawan mace-mace yayin da wasu alluran rigakafin da ba su da rai suna kara yawan mace-mace. Hakanan akwai bambance-bambancen jinsi, kuma jerin alluran rigakafin yana da mahimmanci. Zai fi kyau a ƙare da maganin rigakafi mai rai.
Dokokina na yatsan yatsa shine cewa idan allurar rigakafi tana cikin shirin rigakafi na hukuma a wasu ƙasashe kuma ba a cikin wasu masu matsayi iri ɗaya ba, ba mahimmanci bane a yi allurar. Misali shine rigakafin rotavirus akan cutar gudawa, wanda baya cikin shirin yara a Denmark ko da yake muna da ƙungiyar masu fafutuka da ke tallata shi.
Alurar rigakafin kyanda
Alurar rigakafin kyanda misali ne mai kyau wanda ke raye, raguwar alluran rigakafi suna rage yawan mace-mace fiye da abin da zai yiwu dangane da tasirin da aka yi niyya, a wannan yanayin akan hana cutar kyanda. A wani gwaji da aka yi bazuwar a Bissau, alal misali, yaran da aka yi wa rigakafin cutar kyanda a cikin watanni 6 sun yi. Kashi 70 na yawan mace-mace fiye da yaran da ba a yi musu allurar rigakafi ba, kuma wannan raguwa ba ta kasance saboda rigakafin kamuwa da cutar kyanda ba. Hukumar Lafiya Ta Duniyar An yi kiyasin cewa an samu mutuwar cutar kyanda 128,000 a duniya a shekarar 2021, akasari a tsakanin yara ‘yan kasa da shekaru 5 da ba a yi musu allurar rigakafi ko kuma ba a yi musu allurar ba.
Idan ba mu yi wa yaranmu allurar rigakafin cutar kyanda ba, zai haifar da mutuwar mutane da yawa da kuma raunin kwakwalwa mai tsanani da za a iya kauce masa. Muna da hakki na haɗin gwiwa a kan juna don tabbatar da an yi mana rigakafin domin rigakafin garken yana da mahimmanci. Cutar kyanda tana da saurin yaduwa, kuma don hana afkuwar cutar kyanda, yin allurar kusan kashi 95 cikin XNUMX na al’umma ya zama dole.
Ba a Bukatar Murar Mura ta Shekara-shekara
Hukumomi a duk faɗin duniya, musamman ma tsofaffi, hukumomi suna yi wa mutane allurar rigakafin mura, amma ko kaɗan ba a bayyana cewa wannan kyakkyawan ra'ayi ba ne. A gaskiya ma, akwai dalilai da yawa a yi shakka.
Na farko, da m sakamako karami ne. Mutane 71 ne za su bukaci a yi musu alluran rigakafin kamuwa da cutar guda daya kamar mura da kuma mutane XNUMX don gujewa kamuwa da cutar mura guda daya, kuma allurar ba ta rage yawan shiga asibiti ko hutun kwana a aiki.
Na biyu, yayin da kwayar cutar ke canzawa da sauri, tasirin da aka samu ta hanyar allurar rigakafin zai yi ƙasa da na gwajin da aka yi bazuwar.
Na uku, maganin yana da mummunan tasiri akan tsarin rigakafi. Masu bincike na Kanada sun nuna a cikin bincike daban-daban guda huɗu cewa mutanen da suka karɓi maganin mura na yanayi a cikin 2008 suna da ƙara haɗari na kamuwa da wani nau'i a cikin 2009.
Na hudu, duk allurar rigakafi suna haifar da lahani, wanda zai iya zama mai tsanani. Pandemrix, daya daga cikin maganin mura da aka yi amfani da shi a lokacin bala'in 2009-2010, ya haifar da narcolepsy a cikin yara da matasa tare da wani nau'in nama. Har zuwa shekaru da yawa bayan allurar rigakafin yara da matasa, ba zato ba tsammani mutane na iya fara barci yayin da suke gudanar da ayyukansu na yau da kullun, kuma babu magani.
Na biyar, a koyaushe mu yi la'akari da yiwuwar kamuwa da cutar ba tare da allurar rigakafi ba. Kwayar cutar mura ba sabon abu ba ce kuma da wuya ta shafi yawancin jama'a. A cikin kowace shekara, yuwuwar kamuwa da mura idan ba a yi masa allurar rigakafi ba ta da yawa. Ban taɓa yin allurar mura ba, kuma matata, farfesa a kan ƙananan ƙwayoyin cuta, ba ta taɓa samun ɗaya ba, kuma tare, wataƙila mun sami mura sau biyu tsawon shekaru 135. Amma ba mu sani ba. Lokacin da mutane suka ce suna da mura, yawanci kawai yana nufin ciwo mai kama da mura wanda akwai su da yawa, wanda allurar rigakafi ba ta kariya.
Wasu masu tsattsauran ra'ayi, musamman a Amurka da Ostiraliya, sun ba da umarnin yin rigakafin mura na ma'aikatan kiwon lafiya don kare marasa lafiya. Wannan cin zarafin da aka sani shine mai matukar damuwa da rashin da'a. Haka kuma, a babban bita game da alurar riga kafi na ma'aikatan kiwon lafiya da ke kula da tsofaffi ba su sami tasiri a kan cutar mura da aka tabbatar da dakin gwaje-gwaje ba, ƙananan ƙwayoyin cuta na numfashi, asibiti, mutuwa saboda ƙananan cututtuka na numfashi, ko duk-sakamakon mace-mace.
Wani mai bincike ya ambata cewa, "don mayar da hankali kawai kan hadarin da ma'aikatan da ba a yi musu alluran rigakafi ke haifarwa ba - daukar su a matsayin 'yan gudun hijira ko, mafi muni, dakatar da aikinsu - yayin da suke yin la'akari da hadarin da ma'aikatan da aka yi wa rigakafin ke haifarwa, yana iya haifar da haɗari ga marasa lafiya." Lallai. Alurar riga kafi na iya baiwa ma'aikata rashin tsaro wanda zai iya rage matakin wanke hannu da yuwuwar karuwa, maimakon raguwa, haɗarin kamuwa da marasa lafiya.
Alurar rigakafin HPV: Ba lamari ne mai sauƙi ba
Lokacin da ake zargin maganin rigakafi na HPV da haifar da mummunar cutar da jijiya - postural orthostatic tachycardia syndrome (POTS), hadaddun ciwon ciwo na yanki (CRPS), da ciwon gajiya mai tsanani - Hukumar Kula da Magunguna ta Turai ta share maganin. Duk da haka, ba su binciki batutuwan ba da kansu amma bari masana'antun su yi musu.
Ƙungiya ta bincike ta bincika rahotannin nazarin asibiti da aka mika wa Hukumar Kula da Magunguna ta Turai kuma ta sami mahimmanci karuwa a cikin mummunan cututtuka na jijiyoyi. Wannan abin mamaki ne saboda kusan kowa da kowa a cikin ƙungiyoyin kulawa an yi musu magani da allurar rigakafin hanta ko kuma adjuvant mai ƙarfi na immunogenic, wanda. na iya haifar da illa, yana da wahala a gano illolin rigakafin cutar ta HPV.
Binciken Cochrane na rigakafin HPV bai cika ba kuma sun yi watsi da muhimman shaida na son zuciya. Marubutan sun yi watsi da abubuwan da ba su dace ba kuma sun kasa ambaton cewa wasu daga cikin gwaje-gwajen da aka haɗa ba su bayar da rahoton munanan abubuwan da suka faru ba na tsawon lokacin gwaji. Misali, gwaji guda uku na Gardasil tare da jimlar 'yan mata ko mata 21,441 tare da bin diddigin shekaru hudu kawai sun ba da rahoton munanan abubuwan da suka faru a cikin kwanaki 14 bayan allurar rigakafi ko da yake. yana ɗaukar shekaru a yawancin marasa lafiya kafin a gano cutarwar jijiyoyin jiki mai tsanani.
Marubutan Cochrane sun sami ƙarin mace-mace a cikin ƙungiyoyin rigakafin HPV fiye da a cikin ƙungiyoyin kwatancen, kuma adadin mutuwar ya karu sosai a cikin mata sama da shekaru 25, haɗarin haɗari 2.36 (kashi 95 tazarar amincewa 1.10 zuwa 5.03). Sun dauki hakan a matsayin wata dama ta faru tun da babu wani tsari a cikin musabbabin mutuwa ko kuma a lokacin da ake gudanar da allurar rigakafi da mutuwa.
Duk da haka, ana yawan kuskuren ƙididdige adadin mutuwar. Misali, an bayyana raunin da ya ji rauni a kai da nutsewa a cikin baho, kuma hakan na iya faruwa ta hanyar syncope ko kusa da syncope, wanda shine gane cutar alurar riga kafi wanda zai iya faruwa a kowane lokaci. Mummunan cutarwar jijiya da alama ta haifar da su autoimmune dauki.
Kamfanonin magunguna, EMA da Cochrane sun kira gwaje-gwajen da ake sarrafa placebo, wanda ba su kasance ba. Na ga yana da ban mamaki cewa ba a gwada maganin alurar riga kafi akan placebo ko kuma babu magani saboda wannan yana sa ba zai yiwu a taɓa sanin ainihin cutarwa ba amma cutarwa. Babu wani dalili mai kyau da ya sa ba a gwada allurar rigakafi - waɗanda magungunan rigakafin - ba a gwada su ta hanya mai tsauri kamar sauran magunguna.
EMA ta ayyana cewa adjuvants da aka yi amfani da su a cikin alluran rigakafin don haɓaka martanin rigakafi ba su da lafiya, amma biyar nassoshi idan aka ba da goyon bayan wannan ra'ayi ko dai ba za a iya isa ba ko kuma ba shi da mahimmanci. Bugu da ƙari, babu abin da ke da aminci idan yana aiki. GlaxoSmithKline ya bayyana cewa kwatancenta na tushen aluminum zai iya haifar da lahani, kuma rahotannin binciken asibiti sun nuna cewa wannan ma haka lamarin yake ga adjuvant na Merck.
Yin yanke shawara ba kai tsaye ba ne. Farfaganda a hukumance ta sa mata su yi imani cewa cutar sankarar mahaifa babbar barazana ce ga rayuwarsu, amma wannan ciwon daji yana ba da gudummawa kawai. Kashi 0.5 na duk mace-mace. Don haka, mata kaɗan ne za su iya amfana daga allurar HPV, kuma tun da ba su da kariya daga kowane nau'in HPV, har yanzu ana ba da shawarar yin gwaje-gwaje na yau da kullun har ma ga matan da aka yi musu allurar. Kamar yadda abubuwan da ke haifar da ciwon daji suna girma a hankali, mata za su iya guje wa kamuwa da kansar mahaifa idan sun je a duba. Wannan ya fi yin tasiri fiye da yin alurar riga kafi, amma yana zuwa tare da farashi, misali consection for cancer precursors yana ƙara haɗarin haihuwa kafin haihuwa.
Alurar rigakafin COVID-19: A Mess
Labarin rigakafin COVID-19 a hukumance ana ɗaukarsa a matsayin ɗaya na nasara amma abin da ya fito fili labari ne na babban ha'inci da rashin shaidar kimiyya bayan yawancin shawarwarin.
Gwaje-gwajen da aka yi bazuwar da suka haifar da amincewar gaggawa na rigakafin ya nuna hakan daya kawai daga cikin 50 lokuta masu tsanani na COVID-19 sun faru a cikin kungiyoyin rigakafin. Wannan ya sa akwai yuwuwar cewa alluran sun ceci rayuka, kuma bincike-bincike na gwaje-gwajen ya nuna cewa allurar rigakafi na adenovirus, amma ba na mRNA ba, rage yawan mace-mace muhimmanci.
Sabo ya kasance matsananci, duk da haka. Daga cikin wadanda suka yi ikirarin ingancin kashi 100 na allurar sun hada da FDA, mai baiwa shugaban kasar Amurka shawara Anthony Fauci, da Gwamnatin Ostireliya, Kimiyya Kimiyya, Reuters, CNN, Rediyon Jama'a na Amurka, The Hill, Sky News, Pfizer, Moderana, AstraZeneca, Da kuma Johnson & Johnson. Amfanin yana kusa da kashi 50 kuma mutane da yawa, ciki har da ni, sun kamu da cutar duk da sun sami allurai biyu ko fiye na maganin.
Jami'ai, ciki har da shugaban Amurka Joe Biden, a da ya yi iƙirarin cewa allurar rigakafin kashi 100 na kariya daga kamuwa da cutar zuwa wasu mutane, amma yanzu an yarda cewa babu wata shaida da ke nuna cewa allurar za ta iya hana yaɗuwar cutar.
Bayanin akan yanar na Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) musamman yaudara ce. CDC tana amfani da jargon masana'antu lokacin da'awar cewa allurar "aminci ne kuma masu tasiri." Ya bayyana cewa “ Manya da yara na iya samun wasu illolin daga maganin COVID-19, gami da zafi, ja ko kumburi a wurin allurar, gajiya, ciwon kai, ciwon tsoka, sanyi, zazzabi, da tashin zuciya. Waɗannan illolin suna warwarewa bayan ƴan kwanaki. Mummunan illolin suna rare amma yana iya faruwa."
Hanyar haɗin kai zuwa mummunan sakamako ba ya haifar da wani ambaton abin da waɗannan suke. Amma mun san cewa alurar riga kafi kashe wasu mutane, misali saboda suna iya haifar da myocarditis, yawanci a cikin samari maza, da thromboses.
CDC ta ba da shawarar "kowane mai shekaru 6 da haihuwa ya sami sabuntar rigakafin COVID-19 don kariya daga mummunar cuta." Koyaya, yara suna jure kamuwa da kamuwa da cuta sosai kuma yana da mai yiwuwa cutarwa ga yara alurar riga kafi da COVID-19. Bugu da ƙari, masu haɓakawa na iya zama cutarwa a kowane zamani amma wannan ba sanannen bayanin ba ne. Facebook ya ceci bincike da hira da babban mai binciken allurar rigakafi Farfesa Christine Stabell Benn duk da cewa Hukumar Kula da Magunguna ta Turai ta kuma damu cewa masu haɓaka rigakafin COVID-19 na iya zama "wuce gona da iri na garkuwar jikin mutane kuma yana haifar da gajiyawa.”
Facebook kuma binciken da aka tantance wanda ya nuna cewa mRNA COVID-19 alluran rigakafi na iya raunana amsawar rigakafi kuma su sanya sel na tsarin garkuwar jiki su zama “lalala” idan ana batun yakar cututtukan hoto da na kwayan cuta. Facebook ya kira wannan bincike "bayanan karya. "
Haɗin gwiwar Cochrane, wanda ke da tambarin “Amintaccen bayani,” bai ba da amintaccen bayani ba. An yi amfani da marubutan Cochrane jargon masana'antu a cikin taken bita na su, "Inganci da amincin allurar COVID-19," kodayake na shawo kan Cochrane shekaru da yawa da suka gabata cewa ya kamata mu yi magana game da fa'idodi da illolin ayyukan da muke nazari, bisa yarda da CONSORT jagororin bayar da rahoto mai kyau na lahani a cikin gwaji, wanda na ba da izini a cikin 2004.
Marubutan Cochrane sun kammala da cewa babu wani bambanci ko kadan a cikin munanan abubuwan da suka faru idan aka kwatanta da placebo yayin da Peter Doshi da abokan aikin da suka sake nazarin gwajin mRNA mai mahimmanci sun gano cewa ƙarin wani mummunan lamari ya faru. ga kowane mutum 800 allurar rigakafin mRNA. Labarin su, wanda aka buga watanni hudu kafin nazarin Cochrane, ba a buga shi ba.
Lokacin da na yi nazarin gwaje-gwajen bazuwar mahimmanci, waɗanda aka buga a cikin New England Journal of Medicine kuma a cikin Lancet, Na gano cewa mahimman bayanai game da haɗari masu tsanani da tsanani sun kasance m (Dubi kuma littafina na kyauta, Kwayar cutar ta Sin: ta kashe miliyoyin da 'yancin kimiyya).
Doshi et al.'s sukar na Cochrane review, wanda aka buga cikin review kanta, yana da mahimmanci sosai cewa yana da kyau a kira nazarin Cochrane datti mai amfani da siyasa a ciki, motsa jiki.
Babu shakka cewa allurar COVID-19 sune da yawa wuce gona da iri da wani bangare ga mutanen da ba daidai ba. Yanzu da yawancin mu sun kamu da kamuwa da cuta, ba da shawarar ƙarfafawa bayan haɓakawa da alama mummunan ra'ayi ne.
Alurar Yara
Shirye-shiryen rigakafin yara bambanta da yawa daga kasa zuwa kasa. A cikin Amurka, ana ba da shawarar alluran rigakafi guda 17, a Denmark 10 kawai.
Tunda allurar rigakafi na iya raunana tsarin garkuwar jiki kuma tun da wasu alluran rigakafin da ba su da rai suna ƙara yawan mace-mace, yana da kyau a yi tambaya ko yawancin allurar rigakafi a Amurka na iya haifar da lahani.
Yana da matukar muhimmanci a yi nazarin wannan yiwuwar, amma ina sane da masu bincike guda biyu da suka yi shi. Sun yi da dama karatu kuma sun gano cewa waɗancan ƙasashen da ke buƙatar ƙarin rigakafi ga jariransu suna da yawan mace-macen jarirai, mutuwar jarirai, da mutuwar ƙasa da shekaru biyar. Na sami wannan siginar ƙararrawa wanda yakamata ya haifar da wasu karatu cikin gaggawa.
idon
Takaddama yana da illa ga muhawarar kimiyya da ci gaban kimiyya, kuma yana da illa ga marasa lafiya. Amma ga alluran rigakafi, yana ko'ina.
Peter Aaby, daya daga cikin manyan masu binciken alluran rigakafi a duniya, ya yi lacca game da alluran rigakafin a wurin bude taron tattaunawa na Cibiyar 'Yancin Kimiyya ta Kimiyya a cikin Maris 2019. A farkon Nuwamba 2021, YouTube ya cire bidiyon laccar nasa. Duk abin da ya faɗi daidai ne kuma yana da mahimmanci ga mutanen da ke son fahimtar abin da allurar ke yi. Mun daukaka kara kan wannan muguwar dabi'ar ta cece-kuce, amma abin ya ci tura, saboda haka ni uploaded lecture dinsa akan gidan yanar gizona.
A cikin Fabrairu 2022, wani lauya na Amurka ya rubuta a Harafi mai shafi 3 zuwa Susan Wojcicki, Babban Jami'in Gudanarwa, Tallafin Shari'a, YouTube, yana tambayarta da ta maido da bidiyon Farfesa Aaby game da fa'ida da illolin alluran rigakafin don ci gaba da tattaunawa mai kyau game da kimiyyar likitanci. Lauyan ya sami sako mai sarrafa kansa yana mai cewa bidiyon ya saba wa Ka'idojin Al'umma na YouTube, ya kara da cewa "Idan kuna tunanin an yi amfani da yajin aikin Jagororin Al'umma akan asusun ku cikin kuskure, kuna iya daukaka kara." Lauyan ya daukaka kara kuma bai samu amsa ba.
A watan Yulin 2022, Christine Stabel Benn ta ɗora faifan bidiyo tare da Peter Aaby akan YouTube game da binciken da ya yi a Afirka, wanda galibi ya yi magana game da bincikensa na fa'idodin da ba takamaiman tasirin rigakafin cutar kyanda ba. Amma Aaby ya kuma ambaci yadda ya yi mu'amala da hukumar ta WHO dangane da bullo da maganin rigakafin cutar kyanda mai tsauri, wanda binciken shi da abokan aikinsa ya nuna cewa ana samun karuwar mace-macen yara mata.
Da farko, WHO ba ta mayar da martani ba, amma lokacin da abokan aikin Amurka suka tabbatar da binciken Aaby a Haiti, an cire allurar rigakafin cutar. An yi kiyasin cewa wannan rigakafin zai yi asarar rayuka kusan miliyan 0.5 a kowace shekara a Afirka kadai. Wani darasi ne mai mahimmanci cewa maganin alurar riga kafi mai fa'ida wanda ya ceci miliyoyin rayuka zai iya kashe miliyoyin idan aka yi amfani da shi da yawa. Amma YouTube da sauri cire bidiyon saboda "abin da bai dace ba." Tace yana kashewa. Yana da sauƙi kamar wancan.
A cikin Satumba 2022, enGrama ya yi min tambayoyi na awa daya a Spain game da shirya laifuka a cikin ilimin tabin hankali da masana'antar muggan ƙwayoyi. Na yi magana game da COVID-19 na tsawon mintuna 5, wanda ya sa YouTube ta kawar da duk hirar nan take. Wannan ya kasance abin ban dariya. Abin da na fada gaskiya ne, amma YouTube ma ya ki yarda masu tambayoyin su sauke nasu bidiyon. Daga baya, sun yi nasarar sake haifuwa ta YouTube Studio kuma yanzu ya sake tashi, amma ba tare da haramcin mintuna 5 ba. ina da aka bayyana a fili me suka kasance akai.
Na tabbata - kuma har yanzu ina - cewa cutar ta samo asali ne sakamakon ledar dakin gwaje-gwaje a Wuhan kuma an kera kwayar cutar a can; cewa maimaita alurar riga kafi zai iya raunana da ba da amsa ba; kuma cewa alluran rigakafin na iya haifar da mummunar cutarwa, ko da mutuwa. Dukkanin waxanda kafafen sada zumunta ke ganin haramun ne.
A cikin Satumba 2023, na ƙaddamar da tashar podcast na tushen shaida, Karya Kimiyyar Likita, tare da haɗin gwiwar mai shirya fina-finai Janus Bang. Don guje wa cece-kuce, muna da uwar garken namu amma kuma muna buga labaran akan kafofin watsa labarun. Na yi hira da Farfesa Martin Kulldorff, ɗaya daga cikin marubutan Babban Sanarwa na Barrington, game da "Illalolin kulle-kulle, wajibcin rufe fuska, sa baki, da rashin gaskiya na kimiyya," da Christine Stabell Benn game da "Ayyukan rigakafi, yanki mai rikitarwa. Wasu suna rage yawan mace-mace, wasu suna ƙaruwa, kuma ana amfani da allurar COVID-19 fiye da kima."
A cikin mintuna 7 bayan mun loda waɗannan abubuwan akan YouTube, sun sami wannan lakabin: "alurar rigakafin COVID-19. Koyi game da ci gaban rigakafin daga WHO." Amma wasu bayanan na WHO sun kasance abin tambaya, wanda muka yi magana a ciki jaridarmu:
Menene fa'idodin yin allurar rigakafin COVID-19?
Ya kamata a ko da yaushe mutum ya tambayi mene ne fa'ida da illarsa, na duk wani shiga tsakani. Magungunan suna da kashe wasu mutane saboda myocarditis da thrombosis.
Yin allurar rigakafin zai iya ceton rayuwar ku. Alurar rigakafin COVID-19 sun ceci miliyoyin rayuka.
Menene hujja akan hakan? Alurar rigakafin ba su da tasiri musamman saboda ƙwayoyin cuta suna canzawa.
Yi la'akari da ci gaba da aiwatar da halayen kariya da kariya kamar kiyaye nesa, sanya abin rufe fuska a cikin cunkoson mutane da wuraren da ba su da iska.
The gwajin bazuwar basu sami wani tasiri ba fuskokin fuska.
Ko da kuna da COVID-19, WHO har yanzu tana ba da shawarar a yi muku alurar riga kafi bayan kamuwa da cuta saboda allurar rigakafin yana haɓaka kariya daga mummunan sakamako na kamuwa da cutar COVID-19 na gaba, kuma ana iya kiyaye ku na tsawon lokaci. Bugu da ƙari, ƙayyadaddun rigakafi da ke fitowa daga alurar rigakafi da kamuwa da cuta na iya ba da kariya mafi girma daga bambance-bambancen damuwa.
Ba a rubuta wannan ba, kuma yawancin masu bincike suna shakkar cewa daidai ne.
Don tabbatar da ingantacciyar kariya, yana da mahimmanci don karɓar alluran rigakafin COVID-19 da abubuwan ƙarfafawa waɗanda hukumomin lafiyar ku suka ba ku shawarar.
Ba a rubuta cewa masu haɓakawa suna da amfani ba, da Hukumar Kula da Magunguna ta Turai ya yi gargadin cewa masu haɓakawa na iya zama cutarwa, saboda suna iya raunana tsarin rigakafi.
A cikin duka biyun, a cikin sa'o'i biyu, YouTube ta cire hanyar haɗi zuwa WHO, ba tare da wani bayani ba. Muna tsammanin watakila YouTube ya damu da sunan su. Na yi hira da biyu daga cikin mutane masu ilimi a duniya game da alluran rigakafi waɗanda, a wani lokaci, sun saba wa shawarwarin WHO, bisa ingantaccen kimiyya.
Lokaci yayi canza yanayin game da alluran rigakafi, da kuma yin nazarin su sosai - da haɗin gwiwar su - kafin a iya ba su damar shiga kasuwa.
Kalma ta Ƙarshe game da Tantacewa
Ni da mataimakiyar darakta na, PhD Maryanne Demasi, mun kasa bugawa nazarin tsarin mu na munanan illolin allurar COVID-19 a cikin mujallar likita. Wannan ba don ban san yadda ake yin bincike da buga shi a cikin mujallu masu kyau ba. Na buga takardu sama da 100 a cikin “manyan biyar” (BMJ, Lancet, Jama, Annals na Internal Medicine da kuma New England Journal of Medicine) kuma an ambaci ayyukana na kimiyya sama da sau 190,000.
-
Dokta Peter Gøtzsche shi ne ya kafa Cochrane Haɗin kai, wanda da zarar an yi la'akari da babbar ƙungiyar bincike ta likita mai zaman kanta ta duniya. A cikin 2010 Gøtzsche an nada shi Farfesa na Tsarin Bincike na Clinical da Bincike a Jami'ar Copenhagen. Gøtzsche ya buga fiye da 100 takardu a cikin "manyan biyar" mujallolin likita (JAMA, Lancet, New England Journal of Medicine, British Medical Journal, da Annals of Internal Medicine). Gøtzsche ya kuma rubuta litattafai kan al'amuran kiwon lafiya da suka hada da Magungunan Mutuwa da Laifukan Tsara.
Duba dukkan posts
